Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.004
-0.176 (-8.08%)
May 12, 2026, 1:10 PM EDT - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.36 million as of May 12, 2026. Its market cap has decreased by -17.52% in one year.
Market Cap
7.36M
Enterprise Value
446.88K
1-Year Change
-17.52%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.36M, a decrease of -87.15%. That is a compound annual growth rate of -34.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 8.00M | 36.88% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 8.81M |
| Ernexa Therapeutics | 8.41M |
| PMGC Holdings | 8.37M |
| Evogene | 8.33M |
| NuCana | 8.20M |
| Creative Medical Technology Holdings | 8.06M |
| BioAtla | 7.49M |
| PharmaCyte Biotech | 7.46M |